In the majority of cases, cancer arises due to aberrations in multiple genes. With a virtually unlimited DNA sequencing capacity, we can reveal the changes in the entire genome.” The company aims to ...
Myeloid malignancies are a manifestation of clonal expansion of hematopoietic cells driven by somatic genetic alterations that may arise in a potential background of deleterious germline variants. As ...
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). Characterization of molecular response and progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback